Guangcui He

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Fang Liu, Yuanzhen Cao, Kevin G. Pinz et al. · Blood · 2018 · 137 citations

Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia

Yong Guo, Yi Li, Qingqing Shan et al. · The International Journal of Biochemistry & Cell Biology · 2015 · 43 citations

Hematological Malignancy, Bcr/abl Gene Expression, Medicine +8

The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma

Fangyi Fan, Rui Deng, Hai Yi et al. · International Journal of Oncology · 2017 · 37 citations · Full text

Immunology, Cancer Biology, Tumor Biology +17

MEG3 affects the progression and chemoresistance of T‐cell lymphoblastic lymphoma by suppressing epithelial‐mesenchymal transition via the PI3K/mTOR pathway

Rui Deng, Fangyi Fan, Hai Yi et al. · Journal of Cellular Biochemistry · 2018 · 21 citations

Immunology, Cancer Biology, Tumor Biology +19

Mammalian target of rapamycin inhibitor rapamycin enhances anti‐leukemia effect of imatinib on <scp>P</scp>h<b>+</b> acute lymphoblastic leukemia cells

Xi Yang, Guangcui He, Yuping Gong et al. · European Journal Of Haematology · 2013 · 18 citations

Mixed-phenotype Acute Leukemia, Immunology, Cell Death +16